Accuvest Global Advisors Merck & Co., Inc. Transaction History

Accuvest Global Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $1 Million - $1.09 Million	10,000 New	10,000 $1.09 Million
Q3 2021 Nov 03, 2021	SELL	$71.68 - $78.83 $331,089 - $364,115	-4,619 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $75,723 - $83,758	1,077 Added 30.41%	4,619 $359,000
Q1 2021 Aug 16, 2021	BUY	$68.86 - $81.11 $243,902 - $287,291	3,542 New	3,542 $273,000
Q2 2019 Jul 17, 2019	SELL	$69.84 - $81.59 $404,303 - $472,324	-5,789 Closed	0 $0
Q1 2019 Apr 30, 2019	SELL	$69.58 - $79.36 $411,913 - $469,811	-5,920 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $98,969 - $114,852	-1,517 Reduced 20.4%	5,920 $452,000
Q3 2018 Oct 31, 2018	BUY	$57.69 - $67.84 $429,040 - $504,526	7,437 New	7,437 $528,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Accuvest Global Advisors, based on Form 13F filings with the SEC.

Stay updated on Accuvest Global Advisors with notifications on news.